作者
Brad H Rovin, Dawn J Caster, Daniel C Cattran, Keisha L Gibson, Jonathan J Hogan, Marcus J Moeller, Dario Roccatello, Michael Cheung, David C Wheeler, Wolfgang C Winkelmayer, Jürgen Floege, Sharon G Adler, Charles E Alpers, Isabelle Ayoub, Arvind Bagga, Sean J Barbour, Jonathan Barratt, Daniel TM Chan, Anthony Chang, Jason Chon Jun Choo, H Terence Cook, Rosanna Coppo, Fernando C Fervenza, Agnes B Fogo, Jonathan G Fox, Richard J Glassock, David Harris, Elisabeth M Hodson, Elion Hoxha, Kunitoshi Iseki, J Charles Jennette, Vivekanand Jha, David W Johnson, Shinya Kaname, Ritsuko Katafuchi, A Richard Kitching, Richard A Lafayette, Philip KT Li, Adrian Liew, Jicheng Lv, Ana Malvar, Shoichi Maruyama, Juan Manuel Mejía-Vilet, Chi Chiu Mok, Patrick H Nachman, Carla M Nester, Eisei Noiri, Michelle M O'Shaughnessy, Seza Özen, Samir M Parikh, Hyeong-Cheon Park, Chen Au Peh, William F Pendergraft, Matthew C Pickering, Evangéline Pillebout, Jai Radhakrishnan, Manish Rathi, Pierre Ronco, William E Smoyer, Sydney CW Tang, Vladimír Tesař, Joshua M Thurman, Hernán Trimarchi, Marina Vivarelli, Giles D Walters, Angela Yee-Moon Wang, Scott E Wenderfer, Jack FM Wetzels
发表日期
2019/2/1
期刊
Kidney international
卷号
95
期号
2
页码范围
281-295
出版商
Elsevier
简介
In November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative brought a diverse panel of experts in glomerular diseases together to discuss the 2012 KDIGO glomerulonephritis guideline in the context of new developments and insights that had occurred over the years since its publication. During this KDIGO Controversies Conference on Glomerular Diseases, the group examined data on disease pathogenesis, biomarkers, and treatments to identify areas of consensus and areas of controversy. This report summarizes the discussions on primary podocytopathies, lupus nephritis, anti-neutrophil cytoplasmic antibody–associated nephritis, complement-mediated kidney diseases, and monoclonal gammopathies of renal significance.
引用总数
201920202021202220232024163844462716